BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21822302)

  • 1. Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation.
    Uemura M; Zheng Q; Koh CM; Nelson WG; Yegnasubramanian S; De Marzo AM
    Oncogene; 2012 Mar; 31(10):1254-63. PubMed ID: 21822302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation.
    Zhou H; Wang Y; Lv Q; Zhang J; Wang Q; Gao F; Hou H; Zhang H; Zhang W; Li L
    PLoS One; 2016; 11(10):e0163340. PubMed ID: 27695092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma.
    Ha S; Zhou H; Gautam M; Song Y; Wang C
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00783. PubMed ID: 31169368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative expression of rRNA transcripts and 45S rDNA promoter methylation status are dysregulated in tumors in comparison with matched-normal tissues in breast cancer.
    Karahan G; Sayar N; Gozum G; Bozkurt B; Konu O; Yulug IG
    Oncol Rep; 2015 Jun; 33(6):3131-45. PubMed ID: 25962577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas.
    Bacalini MG; Pacilli A; Giuliani C; Penzo M; Treré D; Pirazzini C; Salvioli S; Franceschi C; Montanaro L; Garagnani P
    BMC Cancer; 2014 May; 14():361. PubMed ID: 24884608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
    Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
    J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
    Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
    Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.
    Karpf AR; Bai S; James SR; Mohler JL; Wilson EM
    Mol Cancer Res; 2009 Apr; 7(4):523-35. PubMed ID: 19372581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.
    Koh CM; Gurel B; Sutcliffe S; Aryee MJ; Schultz D; Iwata T; Uemura M; Zeller KI; Anele U; Zheng Q; Hicks JL; Nelson WG; Dang CV; Yegnasubramanian S; De Marzo AM
    Am J Pathol; 2011 Apr; 178(4):1824-34. PubMed ID: 21435462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.
    Chan MW; Wei SH; Wen P; Wang Z; Matei DE; Liu JC; Liyanarachchi S; Brown R; Nephew KP; Yan PS; Huang TH
    Clin Cancer Res; 2005 Oct; 11(20):7376-83. PubMed ID: 16243810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rRNA gene copy number and nucleolar variation on early development: inhibition of gastrulation in rDNA-deficient chick embryos.
    Delany ME; Muscarella DE; Bloom SE
    J Hered; 1994; 85(3):211-7. PubMed ID: 8014461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription.
    Majumder S; Ghoshal K; Datta J; Smith DS; Bai S; Jacob ST
    J Biol Chem; 2006 Aug; 281(31):22062-22072a. PubMed ID: 16735507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the ribosomal RNA gene promoter is associated with aging and age-related decline.
    D'Aquila P; Montesanto A; MandalĂ  M; Garasto S; Mari V; Corsonello A; Bellizzi D; Passarino G
    Aging Cell; 2017 Oct; 16(5):966-975. PubMed ID: 28625020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.
    Sassa M; Hayashi Y; Watanabe R; Kikumori T; Imai T; Kurebayashi J; Kiuchi T; Murata Y
    Thyroid; 2011 May; 21(5):511-7. PubMed ID: 21449767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure.
    Shiao YH; Crawford EB; Anderson LM; Patel P; Ko K
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):290-6. PubMed ID: 15922014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease.
    Pietrzak M; Rempala G; Nelson PT; Zheng JJ; Hetman M
    PLoS One; 2011; 6(7):e22585. PubMed ID: 21799908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.